• Skip to main content
  • Skip to secondary menu
  • Skip to primary sidebar
  • Skip to secondary sidebar
  • Skip to footer

  • Opinion
  • Health IT
    • Behavioral Health
    • Care Coordination
    • EMR/EHR
    • Interoperability
    • Patient Engagement
    • Population Health Management
    • Revenue Cycle Management
    • Social Determinants of Health
  • Digital Health
    • AI
    • Blockchain
    • Precision Medicine
    • Telehealth
    • Wearables
  • Life Sciences
  • Investments
  • M&A
  • Value-based Care
    • Accountable Care (ACOs)
    • Medicare Advantage

DrFirst Partners with Greenway to Bring Controlled Substance E-prescribing to Greenway Users Nationwide

by Jasmine Pennic 02/24/2014 Leave a Comment

  • LinkedIn
  • Twitter
  • Facebook
  • Email
  • Print

DrFirst, a leading provider of healthcare IT solutions designed to improve clinical outcomes for patients, today announced a partnership to bring electronic prescribing of controlled substances (EPCS) to Greenway’s network of thousands of healthcare providers across primary care and more than 30 specialties.

U.S. providers are increasingly prescribing controlled substances electronically in order to improve safety, efficiency and security. Controlled substance e-prescribing, which is now legal in 47 states and available through nearly one-third of U.S. pharmacies, will become mandatory in the state of New York by March 27, 2015 due to the Internet System for Tracking Over-Prescribing/Prescription Monitoring Program (I-STOP) legislation.

DrFirst’s EPCS Gold℠ 2.0 software will be integrated into Greenway’s Intergy, PrimeSUITE and SuccessEHS systems.

“We chose DrFirst for controlled substance e-prescribing based on its industry-leading expertise, its total-solution support covering the identity proofing process, token management and end-user onboarding, as well as the flexibility of its technology which will enable us to integrate EPCS Gold into all three of our EHR software platforms,” said Mark Janiszewski, Greenway senior vice president of product management.

“DrFirst’s architecture allows us to rapidly integrate and bring controlled substance e-prescribing to our users with a consistent and simple user interface,” he continued. “Since EPCS Gold is also fully compliant with DEA rules and NIST identity-proofing standards, DrFirst’s solution brings our users tremendous value.”

“With the increased scrutiny by the healthcare industry on prescription drug abuse, EPCS Gold provides Greenway customers with a powerful tool to prevent doctor shopping and prescription drug fraud,” said G. Cameron Deemer, president of DrFirst. “As a progressive healthcare technology company, Greenway recognizes and embraces the importance of bringing controlled substance e-prescribing to its users, and delivering the advantage of a single e-prescribing workflow for both legend and controlled drugs.”

To download DrFirst’s 2014 report on electronic prescribing of controlled substances, “The Evolving Landscape for Electronic Prescribing of Controlled Substances (EPCS) — An Industry Briefing for 2014,” visit http://go.drfirst.com/EPCSreport2014.

  • LinkedIn
  • Twitter
  • Facebook
  • Email
  • Print

Tap Native

Get in-depth healthcare technology analysis and commentary delivered straight to your email weekly

Reader Interactions

Primary Sidebar

Subscribe to HIT Consultant

Latest insightful articles delivered straight to your inbox weekly.

Submit a Tip or Pitch

2026 Predictions & Trends

Healthcare 2026 Forecast: Executives on AI Survival, Financial Reckoning, and the End of Point Solutions

2026 Healthcare Executive Predictions: Why the AI “Pilot Era” Is Officially Over

Featured Research Report

Digital Health Funding Hits $14.2B in 2025: A Year of AI Exuberance and Market Bifurcation

Most-Read

Trump Unveils 'The Great Healthcare Plan': A Global Price-Matching Pivot to Settle the Affordability Crisis

Price Reset 2026: How Trump’s ‘Great Healthcare Plan’ Slashes Drug Costs at Trumprx.gov

Anthropic Debuts ‘Claude for Healthcare’ and Opus 4.5 to Engineer the Future of Life Sciences

Anthropic Debuts ‘Claude for Healthcare’ and Opus 4.5 to Engineer the Future of Life Sciences

OpenAI Debuts ChatGPT Health: A ‘Digital Front Door’ That Connects Medical Records to Agentic AI

OpenAI Debuts ChatGPT Health: A ‘Digital Front Door’ That Connects Medical Records to Agentic AI

From Genes to Hackers: The Hidden Cybersecurity Risks in Life Sciences

From Genes to Hackers: The Hidden Cybersecurity Risks in Life Sciences

Utah Becomes First State to Approve AI System for Prescription Renewals

Utah Becomes First State to Approve AI System for Prescription Renewals

NYC Health + Hospitals to Acquire Maimonides in $2.2B Safety Net Overhaul

NYC Health + Hospitals to Acquire Maimonides in $2.2B Safety Net Overhaul

KLAS Report: Why Hospitals Are Choosing Efficiency Over 'Agentic' AI Hype in 2025

KLAS Report: Why Hospitals Are Choosing Efficiency Over ‘Agentic’ AI Hype in 2025

Advanced Primary Care 2026: Top 6 Investments for Health Systems According to Harvard Medical School

Advanced Primary Care 2026: Top 6 Investments for Health Systems According to Harvard Medical School

AI Nutrition Labels: The Key to Provider Adoption and Patient Trust?

AI Nutrition Labels: The Key to Provider Adoption and Patient Trust?

Kristen Hartsell, VP of Clinical Services, RedSail Technologies

The Pharmacy Closures Crisis: How Independent Pharmacies Are Fixing Pharmacy Deserts

Secondary Sidebar

Footer

Company

  • About Us
  • 2026 Editorial Calendar
  • Advertise with Us
  • Reprints and Permissions
  • Op-Ed Submission Guidelines
  • Contact
  • Subscribe

Editorial Coverage

  • Opinion
  • Health IT
    • Care Coordination
    • EMR/EHR
    • Interoperability
    • Population Health Management
    • Revenue Cycle Management
  • Digital Health
    • Artificial Intelligence
    • Blockchain Tech
    • Precision Medicine
    • Telehealth
    • Wearables
  • Startups
  • Value-Based Care
    • Accountable Care
    • Medicare Advantage

Connect

Subscribe to HIT Consultant Media

Latest insightful articles delivered straight to your inbox weekly

Copyright © 2026. HIT Consultant Media. All Rights Reserved. Privacy Policy |